Press Releases

Emiliem Press Releases

August 4, 2008: Emiliem, Inc. and NIH Sign CRADA for Clinical Development of Novel mTOR Inhibitors

May 7, 2008: Emiliem, Inc. Expands Management Team With Industry Veterans Donna Romero and Diane Beuving

April 23, 2008: Emiliem, Inc. Acquires World-wide Rights to Develop and Commercialize a Novel Treatment for Cancer and Other Proliferative and Inflammatory Diseases

May 3, 2007: The Van Andel Research Institute and Emiliem Sign Major Translational Medicine and Biomarker Agreement

February 14, 2007: Sucha Sudarsanam, CSO, to present at IBC Life Sciences conference on Partnering and Outsourcing Models in Biology and Pre-clinical R&D, February 21, 2007, San Diego

January 12, 2007:  Emiliem, Inc. and MIR Preclinical Services sign cancer pharmacology agreement

September 26, 2006:  Edwin P. Ching, J.D., Ph.D., VP Intellectual Property to present workshop on Intellectual Property and Critical Paths

September 18, 2006:  Emiliem, Inc.creates initial Scientific Advisory Board